510(k) Report

510(k) · Cleared

Cleared

Neurometrix Bioamplifier

K083322510(k) TraditionalCleared May 27, 2009196-day reviewClass II21 CFR 882.1835

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Neurometrix, Inc. · GWL Amplifier, Physiological Signal

Cleared on May 27, 2009 as substantially equivalent to K073415 (Eb Neuro S.P.A., 2008) after a 196-day review. Its family tree reaches back 2 generations to 1993.

Decided
May 27, 2009
Review
196 days
Class
Class II
Product code
GWL
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K922488 (1993). 3 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1998: 1 other ancestorK922488 · Phasis Electromyograph · Biosound, Inc. · 1993K073415 · Nemus System; Nemus PC Peripheral · Eb Neuro S.P.A. · 200819901995200020052010
Other ancestors, by generation 2 generations back: 1 other ancestor K073415 · Nemus System; Nemus PC Peripheral · Eb Neuro S.P.A. · 2008K922488 · Phasis Electromyograph · Biosound, Inc. · 19930
  1. Root · 2 generations backK922488 Phasis ElectromyographBiosound, Inc. · 1993
  2. 1 generation backK073415 Nemus System; Nemus PC PeripheralEb Neuro S.P.A. · 2008
  3. This deviceK083322 Neurometrix BioamplifierNeurometrix, Inc. · 2009
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K922488Phasis ElectromyographBiosound, Inc.1993—
−1K073415Nemus System; Nemus PC PeripheralEb Neuro S.P.A.2008—
0 (this device)K083322Neurometrix BioamplifierNeurometrix, Inc.2009—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
FIG. 1 — Lineage of K083322, 1993–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GWL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWL device

  1. #1 K232210 X-trodes System Mscore 10.4 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K073415Nemus System; Nemus PC Peripheral
Summary page 1
…clectromvography amplifier Classification Name: 890.1375 Electromyograph. Diagnostic 3. PREDICATE DE\ICEs · EB Netiro S.p.A. NeMus PC Peripheral (K073415) 4. INTENDED USE The NeuroM etris Bioamplifier is intended for amplification and transmission of the electrical act…
Eb Neuro S.P.A.2008—

Also cleared against K073415: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 3 companies; a new generation was cleared every 15.2 years on median.
  • None of the 3 ancestors has a recall.
  • 3 other devices also cite its predicate K073415.

How does its category compare?

All GWL devices

GWL Amplifier, Physiological Signal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · GWL

1in 2025

2007: 12009: 22010: 12011: 12012: 22014: 12015: 12017: 22018: 12020: 12021: 22022: 12023: 22024: 42025: 1
2007high 4 (2024) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWL

133in 2024

2024: 133 days median
2007high 133 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GWL

1in 2013

2010: 12013: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GWL

1in 2018

2008: 22018: 1
2007high 2 (2008) · low 0 (2007)2025

MAUDE reports naming product code GWL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—02
20092—00
20101—10
20111—00
20122—00
20130—10
20141—00
20151—00
20160—00
20172—00
20181—01
20190—00
20201—00
20212—00
20221—00
20232—00
2024413300
20251—00
20260—0—

What is it indicated for?

The NeuroMetrix Bioamplifier us intended for amplification and transmission of the electrical activity of peripheral nerves and muscles recorded through surface electrodes.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K083322: Neurometrix Bioamplifier.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K083322

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026